These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16637928)

  • 21. Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis.
    Rieckmann P; Mäurer M
    Curr Opin Neurol; 2002 Jun; 15(3):361-70. PubMed ID: 12045738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair.
    Lemus HN; Warrington AE; Rodriguez M
    Neurol Clin; 2018 Feb; 36(1):1-11. PubMed ID: 29157392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signals to promote myelin formation and repair.
    Taveggia C; Feltri ML; Wrabetz L
    Nat Rev Neurol; 2010 May; 6(5):276-87. PubMed ID: 20404842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.
    Owens T
    Curr Opin Neurol; 2003 Jun; 16(3):259-65. PubMed ID: 12858060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early treatment.
    Comi G
    Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of axonal and neuronal damage in multiple sclerosis.
    Dutta R; Trapp BD
    Neurology; 2007 May; 68(22 Suppl 3):S22-31; discussion S43-54. PubMed ID: 17548565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remyelination in multiple sclerosis: from basic science to clinical translation.
    Lubetzki C; Zalc B; Williams A; Stadelmann C; Stankoff B
    Lancet Neurol; 2020 Aug; 19(8):678-688. PubMed ID: 32702337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are there indicators of remyelination in blood or CSF of multiple sclerosis patients?
    Massaro AR
    Mult Scler; 1998 Jun; 4(3):228-31. PubMed ID: 9762679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remyelination in demyelinating disease.
    Scolding NJ; Franklin RJ
    Baillieres Clin Neurol; 1997 Oct; 6(3):525-48. PubMed ID: 10101588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Compensatory mechanisms in multiple sclerosis(review)].
    Peresedova AV; Zavalishin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2 Pt 2):17-22. PubMed ID: 23675603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axonal protection in multiple sclerosis--a particular need during remyelination?
    Smith KJ
    Brain; 2006 Dec; 129(Pt 12):3147-9. PubMed ID: 17132643
    [No Abstract]   [Full Text] [Related]  

  • 35. Early glial responses in murine models of multiple sclerosis.
    Ayers MM; Hazelwood LJ; Catmull DV; Wang D; McKormack Q; Bernard CC; Orian JM
    Neurochem Int; 2004; 45(2-3):409-19. PubMed ID: 15145555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic aspects of multiple sclerosis.
    Boppana S; Huang H; Ito K; Dhib-Jalbut S
    Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E; Pardo LA; Gold R; Linker RA
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Axonal involvement in multiple sclerosis. Current concepts].
    Casanova-Estruch B; Coret-Ferrer F; Landete L; Burgal M
    Rev Neurol; 2000 May 16-31; 30(10):972-6. PubMed ID: 10919198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular approaches for stimulating CNS remyelination.
    Miller RH; Bai L
    Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathology of multiple sclerosis.
    Fox EJ
    Neurology; 2004 Dec; 63(12 Suppl 6):S3-7. PubMed ID: 15623668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.